"Johnson & Johnson ( NYSE:JNJ) ranks fifth with its 2.43% dividend yield, the lowest among these stocks. However, dismissing JNJ on yield alone would be shortsighted. The healthcare giant delivered Q3 2025 revenue of $24.0 billion, up 6.8% year over year, beating estimates. EPS of $2.80 exceeded the $2.76 consensus. The company's dividend track record spans over 60 years of consecutive increases, earning Dividend King status."
"Recent quarterly dividend growth has averaged 4.8%, with the 2025 increase bringing the quarterly payment from $1.24 to $1.30. Net income surged 91% year over year to $5.15 billion in Q3. The company raised fiscal 2026 sales guidance to $93.7 billion while maintaining EPS guidance of $10.85. With a 27.3% profit margin and 30.2% operating margin, JNJ generates substantial cash flow to support dividend growth. The stock's beta of 0.349 makes it particularly defensive during volatility, while its AAA credit rating underscores financial strength."
Social Security cost-of-living adjustments have swung widely, with COLAs of 8.7% in 2023, 3.2% in 2024, and 2.5% in 2025, creating planning challenges for retirees. Dividend stocks that consistently raise payouts across economic cycles can provide a self-adjusting income stream that often outpaces official COLA changes. Five stocks are highlighted for unwavering dividend increases; examples include Johnson & Johnson and Procter & Gamble. Johnson & Johnson yields 2.43%, has 60+ years of increases, strong margins, AAA credit, and raised fiscal 2026 sales guidance. Procter & Gamble holds a 68-year dividend streak with recent revenue and earnings growth.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]